ArticleOncotarget2016

Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.

Woo Sik Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.